Ballentine Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Buy |
2,055
+273
| +15% | +$70.4K | 0.01% | 463 |
|
|
2025
Q1 | $399K | Buy |
1,782
+105
| +6% | +$23.5K | 0.01% | 520 |
|
|
2024
Q4 | $384K | Buy |
1,677
+14
| +0.8% | +$3.2K | 0.01% | 506 |
|
|
2024
Q3 | $406K | Buy |
1,663
+31
| +2% | +$7.57K | 0.01% | 484 |
|
|
2024
Q2 | $312K | Buy |
1,632
+87
| +6% | +$16.7K | 0.01% | 544 |
|
|
2024
Q1 | $306K | Buy |
1,545
+248
| +19% | +$49.1K | 0.01% | 531 |
|
|
2023
Q4 | $223K | Buy |
+1,297
| New | +$223K | ﹤0.01% | 590 |
|
|
2023
Q3 | – | Sell |
-2,139
| Closed | -$467K | – | 641 |
|
|
2023
Q2 | $467K | Buy |
2,139
+43
| +2% | +$9.4K | 0.01% | 330 |
|
|
2023
Q1 | $459K | Buy |
+2,096
| New | +$459K | 0.01% | 314 |
|